Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. [electronic resource]
Producer: 20070802Description: H2598-606 p. digitalISSN:- 0363-6135
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- analogs & derivatives
- Amides -- pharmacology
- Androstadienes -- pharmacology
- Animals
- Apoptosis -- drug effects
- Cardiotonic Agents -- pharmacology
- Coronary Circulation -- drug effects
- Cytoskeletal Proteins -- metabolism
- Enzyme Activation
- In Vitro Techniques
- Intracellular Signaling Peptides and Proteins -- antagonists & inhibitors
- Male
- Membrane Proteins -- metabolism
- Microfilament Proteins -- metabolism
- Multiprotein Complexes -- metabolism
- Myocardial Infarction -- enzymology
- Myocardial Reperfusion Injury -- enzymology
- Myocardium -- enzymology
- NG-Nitroarginine Methyl Ester -- pharmacology
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type III -- antagonists & inhibitors
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation
- Protein Kinase Inhibitors -- pharmacology
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyridines -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Signal Transduction -- drug effects
- Wortmannin
- rho-Associated Kinases
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.